Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deferred Tax LiabilityOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Prestige Consumer Healthcare (PBH) Total Debt (2016 - 2024)

Historic Total Debt for Prestige Consumer Healthcare (PBH) over the last 16 years, with Q1 2024 value amounting to $1.1 billion.

  • Prestige Consumer Healthcare's Total Debt fell 1634.61% to $1.1 billion in Q1 2024 from the same period last year, while for Mar 2024 it was $1.1 billion, marking a year-over-year decrease of 1634.61%. This contributed to the annual value of $1.1 billion for FY2024, which is 1634.61% down from last year.
  • As of Q1 2024, Prestige Consumer Healthcare's Total Debt stood at $1.1 billion, which was down 1634.61% from $1.3 billion recorded in Q1 2023.
  • In the past 5 years, Prestige Consumer Healthcare's Total Debt ranged from a high of $1.7 billion in Q1 2020 and a low of $6.0 million during Q3 2021
  • In the last 5 years, Prestige Consumer Healthcare's Total Debt had a median value of $1.5 billion in 2021 and averaged $1.3 billion.
  • Per our database at Business Quant, Prestige Consumer Healthcare's Total Debt tumbled by 9961.24% in 2021 and then dropped by 20.24% in 2022.
  • Prestige Consumer Healthcare's Total Debt (Quarter) stood at $1.5 billion in 2020, then plummeted by 99.61% to $6.0 million in 2021, then surged by 24510.97% to $1.5 billion in 2022, then decreased by 8.86% to $1.3 billion in 2023, then dropped by 16.35% to $1.1 billion in 2024.
  • Its Total Debt stands at $1.1 billion for Q1 2024, versus $1.3 billion for Q1 2023 and $1.5 billion for Q1 2022.